RICHESSE Collafilo (Atelo Collagen 3%)
$49.00
RICHESSE Collafilo® (Atelo Collagen 3%) is an FDA-cleared regenerative filler utilizing medical-grade atelocollagen with ≥98% telopeptide removal. Clinically proven to stimulate 327% Type I collagen production and reduce antigenicity by 90%, it provides dual functionality for facial contouring and wound management with 12-18 month.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $47.04 |
| 16-30 | 6% | $46.06 |
| 31-Unlimited | 8% | $45.08 |
RICHESSE Collafilo®
Advanced Atelo Collagen 3% Dermal Regenerator
Revolutionary Collagen Regeneration
FDA-cleared dual-purpose regenerative filler containing 30mg/mL medical-grade atelocollagen with ≥98% telopeptide removal. Clinically proven to reduce antigenicity by 90% while stimulating 327% Type I collagen production within 12 weeks. Provides 12-18 month longevity with <0.1% hypersensitivity rate. Accelerates tissue repair by 35% versus traditional fillers.
Key Benefits
Superior Safety Profile
90% antigenicity reduction through telopeptide engineering
Dual-Action Efficacy
Immediate volumizing + progressive collagen neogenesis (up to 18 months)
Tissue Regeneration
Enhances angiogenesis (↑41% vs HA fillers) and epithelialization
Surgical Enhancement
Reduces post-op bleeding by 68% when used as surgical adjunct
Advanced Technology
Collagen Engineering
- Telopeptide-free formulation (≥98% removal)
- ISO 13485 and EU MDR compliant
- 327% Type I collagen stimulation
Dual Mechanism
- Immediate structural support
- Sustained neocollagenesis activation
- 35% faster epithelial closure in chronic ulcers
Packaging Specifications
Storage
15-25°C in original packaging. Avoid freezing.
Shelf Life
24 months unopened. Use within 4hrs after activation.
Sterilization
EO gas sterilized. Batch-specific CoA available.
Clinical Protocol
Indications
- Nasolabial folds: 0.8-1.2mL/side
- Marionette lines: 0.3-0.5mL/cm
- Cheek augmentation
Technique
- Linear threading (30° angle)
- 0.1mL depot for chin augmentation
Contraindications
- Active skin infection
- Collagen vascular diseases
- Pregnancy
Requires 21G+ cannula for vascular risk areas. Contraindicated in patients with autoimmune disorders or anticoagulant therapy.
Important Clinical Notice
Individual results may vary based on tissue characteristics and injection technique. For medical use only. Complies with ISO 13485 and EU MDR standards. Clinical outcomes based on manufacturer studies.

Reviews
There are no reviews yet.